共 50 条
- [41] Effects of Dapagliflozin on Anemia in Patients With CKD With or Without Type 2 Diabetes: A Pre-Specified Analysis of the DAPA-CKD Trial JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 43 - 43
- [42] Psychometric Properties of the SF-36 Vitality Scale in Patients With Anemia of CKD JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 234 - 234
- [43] Resolved: Targeting a Higher Hemoglobin Is Associated with Greater Risk in Patients with CKD Anemia JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (07): : 1436 - 1443
- [46] Efficacy and Safety of Roxadustat in Patients with Anemia of Non-Dialysis-Dependent CKD (NDD-CKD) Treated Continuously for ≥2 Years JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 180 - 180
- [49] Vadadustat for Treatment of Anemia in Patients with Dialysis-Dependent CKD Receiving Peritoneal Dialysis JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 184 - 184
- [50] Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study) CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (03) : 349 - 361